Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

52.11 -1.85 (-3.43%)
Streaming Delayed Price Updated: 10:03 AM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,849,755
Open 54.32
Bid (Size) 52.06 (20)
Ask (Size) 52.11 (3)
Prev. Close 53.96
Today's Range 50.85 - 54.34
52wk Range 15.73 - 72.98
Shares Outstanding 191,922,517
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hims & Hers Health (HIMS): Buy, Sell, or Hold Post Q2 Earnings?
The past six months have been a windfall for Hims & Hers Health’s shareholders. The company’s stock price has jumped 55.7%, hitting $54 per share. This run-up might have investors contemplating their... 
Via StockStory
Hims & Hers Faces FDA Heat As Commissioner Martin Makary Calls Out Super Bowl Ad For Hiding Drug Risks
FDA Commissioner Martin Makary said Hims & Hers broke federal law with its Super Bowl ad promoting weight-loss drugs without disclosing side effects, and called it "the most overt breach" of FDA... 
Via Benzinga

Performance

YTD
+106.8%
+106.8%
1 Month
+15.5%
+15.5%
3 Month
-12.8%
-12.8%
6 Month
+50.2%
+50.2%
1 Year
+220.1%
+220.1%

More News

Read More
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why
Via StockStory
Topics Artificial Intelligence
Not Just Opendoor & GoPro: JPMorgan Identifies 4 Emerging 'Meme Stocks' Firing Up Social Media And Hedge Fund Shorts
Via Stocktwits
3 Cash-Producing Stocks on Our Watchlist
Via StockStory
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why
Via StockStory
Hims & Hers Stock Rises After Company Launches Treatment Plans For Low Testosterone
Via Stocktwits
Why Hims & Hers Health (HIMS) Stock Is Trading Up Today
Via StockStory
Hims & Hers Stock Jumps On Long-Awaited Foray Into Testosterone
Via Investor's Business Daily
Topics ETFs
Hims & Hers Bets On Hormonal Health To Revive Investor Confidence
Via Benzinga
Hims Launches New Category in Men’s Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments
From Hims & Hers
Via Business Wire
Hims & Hers To Launch Low Testosterone Treatments for Men As Weight-Loss Drug Sales Slow
Via Stocktwits
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Hims & Hers Health (HIMS) Stock Is Up Today
Via StockStory
Topics ETFs Economy
4 Top Stocks to Buy in September
Via The Motley Fool
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
EXCLUSIVE: August's 20 Most-Searched Tickers On Benzinga Pro – Where Do Opendoor, Palantir, BitMine Immersion, Apple Stock Rank?
Via Benzinga
HIMS & HERS ALERT: Bragar Eagel & Squire, P.C. is Investigating Hims & Hers Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire
Via Benzinga
Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers
Via Benzinga
Topics ETFs
HIMS FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the August 25th Deadline for the Hims Lawsuit and Urges Investors to Contact The Firm
From Bragar Eagel & Squire
Via GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health
From Faruqi & Faruqi, LLP
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
From Pomerantz LLP
Via GlobeNewswire
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Seeking Recovery for Investors - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit

Frequently Asked Questions

Is Hims & Hers Health, Inc. Class A Common Stock publicly traded?
Yes, Hims & Hers Health, Inc. Class A Common Stock is publicly traded.
What exchange does Hims & Hers Health, Inc. Class A Common Stock trade on?
Hims & Hers Health, Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Hims & Hers Health, Inc. Class A Common Stock?
The ticker symbol for Hims & Hers Health, Inc. Class A Common Stock is HIMS on the New York Stock Exchange
What is the current price of Hims & Hers Health, Inc. Class A Common Stock?
The current price of Hims & Hers Health, Inc. Class A Common Stock is 52.11
When was Hims & Hers Health, Inc. Class A Common Stock last traded?
The last trade of Hims & Hers Health, Inc. Class A Common Stock was at 09/16/25 10:03 AM ET
What is the market capitalization of Hims & Hers Health, Inc. Class A Common Stock?
The market capitalization of Hims & Hers Health, Inc. Class A Common Stock is 10.00B
How many shares of Hims & Hers Health, Inc. Class A Common Stock are outstanding?
Hims & Hers Health, Inc. Class A Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.